[
    [
        {
            "time": "",
            "original_text": "实际控制人竟是“五棵松”东家 华熙生物转道科创板 高毛利率面临考验 | 科创视野",
            "features": {
                "keywords": [
                    "实际控制人",
                    "五棵松",
                    "华熙生物",
                    "科创板",
                    "高毛利率",
                    "考验"
                ],
                "sentiment_score": 0.2,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技",
                    "科创板"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "实际控制人竟是“五棵松”东家 华熙生物转道科创板 高毛利率面临考验 | 科创视野",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]